Cessation Clinics

Centre de Sevrage du Tabac a L'Hopital Hôtel-Dieu de France

Introduction:

The Smoking Cessation Center at Hôtel-Dieu de France has a specialized consultation and support unit dedicated for smoking cessation and composed of a team of nurses, doctors, psychologists and nutritionists. Its objective is to medically support smokers willing to quit through weekly consultations and activities, follow up with hospitalized patients, spread awareness and partake in tobacco prevention campaigns on a national and international level

Name	Address	Technique	Duration	Cost	Phone	Email	Website
Centre de Sevrage du Tabac	Hôtel-Dieu de France – Achrafieh, Beirut	Medical evidence based treatment	3- 6 months (more or less)	It will depend on each individual case	01/604000 ext. 8081- 8082	sevragetabac@hdf.usj.edu.lb	https://www.hdf.usj.edu.lb/cst

Stop Smoking Lebanon by Maguy Nassar

Introduction:

For more than 20 years of experience with smokers or social smokers I advise them to stop or limit their addiction, it's not a dream it's a great technology in one session.
My name is Maguy Nassar, I do acupuncture by light on ears and face by stimulating 5 energetics points (the will, the gesture,nicotine,stress&bulimia)
One session No side effects, even pregnant woman can benefit from the session.
Duration: 30 to 45 minutes.

Name	Address	Technique	Duration	Cost	Phone	Email	Website
Stop Smoking Lebanon Center	Jdeideh & Zgharta	Laser-acupuncture	30 to 45 minutes	-	03/680691	maguynassar@gmail	Stopsmokinglebanon.com

REALIZE Center
Smoking Cessation Program

Introduction:

The smoking cessation program includes 10 sessions of counseling and therapy under the supervision of a certified psychotherapist, a dietician and a physician.

Sessions are based on international clinical guidelines that involve motivational sessions, learning behavior modification, nicotine replacement therapy and others.

Name	Address	Technique	Duration	Cost	Phone	Email	Website
REALIZE Center	Jal El Dib	Psychotherapy and nicotine replacement therapy	around 3 months (depends on each individual)	-	70/387738	rachellebardawil@gmail.com
REALIZE Center	Jal El Dib	Psychotherapy and nicotine replacement therapy	around 3 months (depends on each individual)	-	70/926829	realizetherapycenter@gmail.com

All

ATC	Name	B/G ↑	Ingredients	Dosage	Form	Price
L04AX06	IMNOVID	B	Pomalidomide - 2mg	2mg	Capsule, hard	290,515,206 L.L
L04AX06	IMNOVID	B	Pomalidomide - 4mg	4mg	Capsule, hard	290,515,206 L.L
N02CC01	IMIGRAN	B	Sumatriptan (succinate) - 100mg	100mg	Tablet, film coated	616,824 L.L
N02CC01	IMIGRAN	B	Sumatriptan (succinate) - 50mg	50mg	Tablet, film coated	378,964 L.L
M01AB01	INDOCID	B	Indometacin - 100mg	100mg	Suppository	424,910 L.L
A07DA03	IMODIUM	B	Loperamide HCl - 2mg	2mg	Capsule	138,416 L.L
A07DA03	IMODIUM INSTANTS	B	Loperamide HCl - 2mg	2mg	Tablet, orodispersible	451,531 L.L
N05AX13	INVEGA	B	Paliperidone - 9mg	9mg	Tablet, prolonged release	5,825,557 L.L
N05AX13	INVEGA	B	Paliperidone - 3mg	3mg	Tablet, prolonged release	5,386,121 L.L
N05AX13	INVEGA	B	Paliperidone - 6mg	6mg	Tablet, prolonged release	5,825,557 L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 100mg	100mg	Injectable suspension, prolonged release	19,068,505 L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 75mg	75mg	Injectable suspension, prolonged release	15,240,102 L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 50mg	50mg	Injectable suspension, prolonged release	9,661,754 L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 150mg	150mg	Injectable suspension, prolonged release	27,480,995 L.L
L01EA05	ICLUSIG	B	Ponatinib - 15mg	15mg	Tablet, film coated	103,555,839 L.L
L01EA05	ICLUSIG	B	Ponatinib - 45mg	45mg	Tablet, film coated	207,092,651 L.L
L01EB01	IRESSA	B	Gefitinib - 250mg	250mg	Tablet, fim coated	135,027,509 L.L
A07FA51	INFLORAN	B	Bifidobacterium infantis - 1milliard, Lactobacillus acidophilus - 1milliard		Capsule	647,732 L.L
L01EF01	IBRANCE	B	Palbociclib - 75mg	75mg	Capsule	172,164,216 L.L
J07BB01	INFLUVAC TETRA	B	Influenza virus surface antigens inactivated (haemagglutinin and neuraminidase) - 15mcg/4strains/0.5ml		Injectable suspension	970,254 L.L
L01EF01	IBRANCE	B	Palbociclib - 75mg	75mg	Tablet, film coated	172,164,216 L.L
J07BB02	INFLUVAC	B	Grippal virus surface antigen 3strains - 15mcgx3strains/0.5ml		Injectable suspension	573,821 L.L
L01EF01	IBRANCE	B	Palbociclib - 100mg	100mg	Capsule	172,164,216 L.L
L01EF01	IBRANCE	B	Palbociclib - 100mg	100mg	Tablet, film coated	172,164,216 L.L
L01EF01	IBRANCE	B	Palbociclib - 125mg	125mg	Capsule	172,164,216 L.L
L01EF01	IBRANCE	B	Palbociclib - 125mg	125mg	Tablet, film coated	172,164,216 L.L
J07CA06	INFANRIX IPV + HIB	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg		Injectable dry powder+suspension	3,014,239 L.L
J07CA09	INFANRIX HEXA	B	Diphteria toxoid purified (Prefilled syringe) - ?30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - ?40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml		Injectable suspension	4,230,416 L.L
L01EK01	INLYTA	B	Axitinib - 5mg	5mg	Tablet, film coated	184,486,511 L.L
L01EK01	INLYTA	B	Axitinib - 1mg	1mg	Tablet, film coated	57,595,789 L.L